BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB
15 results:

  • 1. Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells.
    Scheidemann ER; Demas DM; Hou C; Ma J; He W; Sharma G; Schultz E; Weilbaecher KN; Shajahan-Haq AN
    Mol Carcinog; 2024 Feb; 63(2):209-223. PubMed ID: 37818798
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
    Yan W; Shi X; Wang H; Liao A; Yang W
    J Transl Med; 2022 Jun; 20(1):296. PubMed ID: 35773729
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Disrupting the MYC-tfeb Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy.
    Fernandez MR; Schaub FX; Yang C; Li W; Yun S; Schaub SK; Dorsey FC; Liu M; Steeves MA; Ballabio A; Tzankov A; Chen Z; Koomen JM; Berglund AE; Cleveland JL
    Cancer Res; 2022 Apr; 82(7):1234-1250. PubMed ID: 35149590
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Translocation carcinomas of the kidney.
    Argani P
    Genes Chromosomes Cancer; 2022 May; 61(5):219-227. PubMed ID: 34704642
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Improved personalized survival prediction of patients with diffuse large B-cell lymphoma using gene expression profiling.
    Mosquera Orgueira A; Díaz Arias JÁ; Cid López M; Peleteiro Raíndo A; Antelo Rodríguez B; Aliste Santos C; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; González Pérez MS; Pérez Encinas MM; Fraga Rodríguez MF; Bello López JL
    BMC Cancer; 2020 Oct; 20(1):1017. PubMed ID: 33087075
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cyclodextrin Prevents Abdominal Aortic Aneurysm via Activation of Vascular Smooth Muscle Cell Transcription Factor EB.
    Lu H; Sun J; Liang W; Chang Z; Rom O; Zhao Y; Zhao G; Xiong W; Wang H; Zhu T; Guo Y; Chang L; Garcia-Barrio MT; Zhang J; Chen YE; Fan Y
    Circulation; 2020 Aug; 142(5):483-498. PubMed ID: 32354235
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors.
    Sivakumaren SC; Shim H; Zhang T; Ferguson FM; Lundquist MR; Browne CM; Seo HS; Paddock MN; Manz TD; Jiang B; Hao MF; Krishnan P; Wang DG; Yang TJ; Kwiatkowski NP; Ficarro SB; Cunningham JM; Marto JA; Dhe-Paganon S; Cantley LC; Gray NS
    Cell Chem Biol; 2020 May; 27(5):525-537.e6. PubMed ID: 32130941
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [tfeb-amplified renal cell carcinoma. A case report and review of the literature].
    Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
    Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.
    Cajaiba MM; Dyer LM; Geller JI; Jennings LJ; George D; Kirschmann D; Rohan SM; Cost NG; Khanna G; Mullen EA; Dome JS; Fernandez CV; Perlman EJ
    Cancer; 2018 Aug; 124(16):3381-3389. PubMed ID: 29905933
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding tfeb-mediated autophagic flux.
    Wang K; Zhang T; Lei Y; Li X; Jiang J; Lan J; Liu Y; Chen H; Gao W; Xie N; Chen Q; Zhu X; Liu X; Xie K; Peng Y; Nice EC; Wu M; Huang C; Wei Y
    Autophagy; 2018; 14(2):269-282. PubMed ID: 29172997
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition.
    Gayle S; Landrette S; Beeharry N; Conrad C; Hernandez M; Beckett P; Ferguson SM; Xu T; Rothberg J; Lichenstein H
    Autophagy; 2017 Jun; 13(6):1082-1083. PubMed ID: 28350209
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.
    Gayle S; Landrette S; Beeharry N; Conrad C; Hernandez M; Beckett P; Ferguson SM; Mandelkern T; Zheng M; Xu T; Rothberg J; Lichenstein H
    Blood; 2017 Mar; 129(13):1768-1778. PubMed ID: 28104689
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation.
    Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR
    Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [The translocation carcinoma: A pediatric renal tumor also in adults].
    Bruder E; Moch H
    Pathologe; 2016 Mar; 37(2):159-65. PubMed ID: 26972595
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cloning of an Alpha-tfeb fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
    Davis IJ; Hsi BL; Arroyo JD; Vargas SO; Yeh YA; Motyckova G; Valencia P; Perez-Atayde AR; Argani P; Ladanyi M; Fletcher JA; Fisher DE
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6051-6. PubMed ID: 12719541
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.